We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radioactive Microscopic Beads Could Treat Patients with Kidney Cancer

By HospiMedica International staff writers
Posted on 07 Oct 2025

Kidney cancer occurs when cells in the kidney become malignant and begin to grow uncontrollably, often leading to limited treatment options when surgery is not viable. More...

Many patients are ineligible for surgery due to advanced age or underlying health issues, and the disease typically resists chemotherapy and standard radiation therapy. Now, researchers are testing a new approach that delivers targeted radiation internally, potentially improving outcomes for patients who have few alternatives.

Researchers at the London Health Sciences Centre Research Institute (LHSCRI, London, ON, Canada) have launched a Phase II clinical trial using microscopic radioactive beads inserted directly into blood vessels feeding kidney tumors. The treatment employs TheraSphere Glass Microspheres, which are tiny glass beads containing radioactive Yttrium (Y-90), to deliver concentrated internal radiation to cancerous tissues. This method targets tumors from within the body, minimizing harm to surrounding organs and preserving kidney function.

The Phase II study will include up to 16 patients with localized kidney cancer who are ineligible for surgery. The trial will analyze tumor response, disease progression, and overall treatment efficacy. The beads, already approved as a standard of care for treating liver cancer, are being repurposed for renal cell carcinoma to determine whether similar success can be achieved in this new application.

Initial projections indicate that the radioactive beads can deliver up to ten times the radiation dose of external treatments, increasing the likelihood of destroying cancer cells. By focusing radiation directly within the tumor’s blood supply, the therapy aims to spare healthy tissue and reduce side effects. The results will inform the feasibility of expanding to a larger, multicenter Phase II study to validate effectiveness across broader patient populations.

The researchers hope this work will lead to a viable non-surgical treatment for kidney cancer, improving patient outcomes and reducing dependence on dialysis by preserving kidney function. If proven effective, the approach could redefine internal radiotherapy applications beyond liver cancer and open new pathways for targeted radiation therapies in other solid tumors.

“We expect these beads can deliver 10 times the amount of radiation when compared to external radiation,” said Dr. Derek Cool, Associate Scientist at LHSCRI. “By targeting the therapy directly in the tumour, we think we can avoid damage to surrounding organs while also delivering an incredibly strong dose of radiation with a higher potential of destroying cancer cells.”

Related Links:
LHSCRI


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
From left: Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel Ode, Head of Ericsson Singapore, Brunei and Philippines and Global Customer Unit Singtel, signed a Memorandum of Understanding to advance connected healthcare, 5G-Advanced and 6G technology, as well as connected intelligence. (Photo courtesy of National University Health System)

Healthcare Partnership Creates Testbed for Advanced Connectivity and AI Applications

Hospitals face growing care complexity, aging populations, and pressure to extend monitoring beyond traditional inpatient settings. Meeting these demands requires more responsive clinical workflows and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.